Navigation Links
BrainCells Inc. Appoints David E. Thompson to Its Board of Directors
Date:12/2/2008

SAN DIEGO, Dec. 2 /PRNewswire/ -- BrainCells Inc. (BCI), a biopharmaceutical company utilizing its platform technology to identify and develop compounds that promote the growth of new neurons for the treatment of central nervous system (CNS) diseases, announced today the appointment of David E. Thompson to its board of directors. Thompson is a veteran of the pharmaceutical industry, with a 30-year tenure at Eli Lilly and Co. where he focused on building the company while leading corporate strategy, business development, corporate ventures and alliance management.

"Dave is an industry veteran with broad experience and numerous relationships in the pharmaceutical and biotech world," said Jim Schoeneck, BrainCells CEO. "He will be a valuable resource as we execute corporate strategy and potential transactions around our neurogenesis platform technology and compounds in clinical development, including BCI-540, for which we anticipate Phase II data for the treatment of depression and anxiety in 2009."

Thompson conducted a successful 30-year career at Eli Lilly and its affiliates which culminated in a position as vice president of corporate strategy and business development. During his tenure at Eli Lilly, Thompson focused his expertise on all aspects of Lilly's business, holding numerous positions including director of corporate new product planning and licensing, president and general manager of Eli Lilly Canada, president/CEO of IVAC Corporation and vice president of pharmaceutical product management and licensing. Currently, Thompson is executive chairman of Bayhill Therapeutics, Inc. and is a member of the board of directors for Anthera Pharmaceuticals, Inc. Born in Lansing, Michigan, he is a graduate of Michigan State University with a BS and MBA.

"BCI's scientific application of neurogenesis for the treatment of mood disorders and other CNS diseases has the potential to revolutionize th
'/>"/>

SOURCE BrainCells Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. REVISED: BrainCells Inc. Expands Series B Financing to $50 Million
2. BrainCells Inc. Expands Series B Financing to $50 Million
3. BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing
4. Cerimon Pharmaceuticals Appoints James S. Shannon, M.D., to Board of Directors
5. Cyntellect Appoints Former BD Biosciences Executive Andre Lubarsky as Director of Sales - North America
6. InCode BioPharmaceutics Appoints New President and CEO
7. Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
8. GeneNews appoints Canadian Colorectal Cancer Advisory Board
9. WuXi PharmaTech Appoints Ying Han to Its Board of Directors
10. TorreyPines Therapeutics Appoints Evelyn Graham Chief Executive Officer and a Member of the Board of Directors
11. Accumetrics Appoints John J. Young, MD Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 2Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 3Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 4Dendreon Announces Proposed Public Offering of Common Stock 2Dendreon Announces Proposed Public Offering of Common Stock 3Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit 2Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit 3Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit 4Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 2Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 3Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 4Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 5Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 6Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 7Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective 8
Breaking Biology News(10 mins):Abundance of a look-alike species clouds population status of a million dollar fish 2Abundance of a look-alike species clouds population status of a million dollar fish 3Charles Darwin: More than the origin 2Charles Darwin: More than the origin 3Oceans day at International Climate Change Conference 25 Simple Ways to Take 10 Years Off Your Face 55377 15 Simple Ways to Take 10 Years Off Your Face 55377 25 Simple Ways to Take 10 Years Off Your Face 55377 35 Simple Ways to Take 10 Years Off Your Face 55377 4Environmental Tectonics Corporations BioMedical Systems Division Announces First BARA MED 28R 29 Monoplace Hyperbaric Chamber Sale in Romania 55373 1Environmental Tectonics Corporations BioMedical Systems Division Announces First BARA MED 28R 29 Monoplace Hyperbaric Chamber Sale in Romania 55373 2Environmental Tectonics Corporations BioMedical Systems Division Announces First BARA MED 28R 29 Monoplace Hyperbaric Chamber Sale in Romania 55373 3Environmental Tectonics Corporations BioMedical Systems Division Announces First BARA MED 28R 29 Monoplace Hyperbaric Chamber Sale in Romania 55373 4Many Hospitals Are Not Ready for H1N1 3A Nurse Survey Shows Deficiencies in Hospital Swine Flu Readiness 55369 1Many Hospitals Are Not Ready for H1N1 3A Nurse Survey Shows Deficiencies in Hospital Swine Flu Readiness 55369 2Many Hospitals Are Not Ready for H1N1 3A Nurse Survey Shows Deficiencies in Hospital Swine Flu Readiness 55369 3